1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          North America Peptide Therapeutics Market – By Type

1.3.2          North America Peptide Therapeutics Market – By Route of Administration

1.3.3          North America Peptide Therapeutics Market – By Synthesis Technology

1.3.4          North America Peptide Therapeutics Market – By Application

1.3.5          North America Peptide Therapeutics Market – By Country

2.           Peptide Therapeutics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Peptide Therapeutics – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          North America – PEST Analysis

4.3          Expert Opinion

5.           Peptide Therapeutics Market – Key Market Dynamics

5.1          Market Drivers

5.1.1          Growing Investments on Peptide Therapeutics

5.1.2          Increasing Prevalence of Metabolic Disorders and Infectious Diseases

5.2          Market Restraints

5.2.1          Operational Limitations of Peptides

5.3          Market Opportunities

5.3.1          Strong Pipeline and Applications of Peptide Drugs

5.4          Future Trends

5.4.1          Emphasis on Automatic Peptide Synthesis

5.5          Impact Analysis

6.           Peptide Therapeutics Market – North America Analysis

6.1          North America Peptide Therapeutics Market Revenue Forecast and Analysis

7.           Peptide Therapeutics Market Analysis – By Type

7.1          Overview

7.2          Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

7.3          Generic

7.3.1          Overview

7.3.2          Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

7.4          Innovative

7.4.1          Overview

7.4.2          Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.           Peptide Therapeutics Market Analysis – By Route of Administration

8.1          Overview

8.2          Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

8.3          Parenteral

8.3.1          Overview

8.3.2          Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.4          Oral

8.4.1          Overview

8.4.2          Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.5          Mucosal

8.5.1          Overview

8.5.2          Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.6          Pulmonary

8.6.1          Overview

8.6.2          Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.7          Others

8.7.1          Overview

8.7.2          Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.           Peptide Therapeutics Market Analysis – By Synthesis Technology

9.1          Overview

9.2          Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

9.3          Solid Phase Peptide Synthesis (SPPS)

9.3.1          Overview

9.3.2          Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.4          Liquid Phase Peptide Synthesis (LPPS)

9.4.1          Overview

9.4.2          Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.5          Hybrid Technology

9.5.1          Overview

9.5.2          Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.        Peptide Therapeutics Market– Application

10.1        Overview

10.2        Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

10.3        Cancer

10.3.1        Overview

10.3.2        Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.4        Cardiovascular Disorders

10.4.1        Overview

10.4.2        Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.5        Metabolic Disorder

10.5.1        Overview

10.5.2        Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.6        Respiratory Disorders

10.6.1        Overview

10.6.2        Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.7        Pain

10.7.1        Overview

10.7.2        Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.8        Dermatology

10.8.1        Overview

10.8.2        Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

11.        Peptide Therapeutics Market – North America Analysis

11.1        North America: Peptide Therapeutics Market

11.1.1        Overview

11.1.2        North America: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.3        North America: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.4        North America: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.5        North America: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.6        North America: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.7        North America: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

11.1.8        US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1          US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2          US: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.8.3          US: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.8.4          US: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.8.5          US: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.9        Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1          Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2          Canada: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.9.3          Canada: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.9.4          Canada: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.9.5          Canada: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.10      Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1        Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2        Mexico: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.10.3        Mexico: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.10.4        Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.10.5        Mexico: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

12.        Impact of COVID-19 Pandemic on North America Peptide Therapeutics Market

12.1        North America: Impact Assessment of COVID-19 Pandemic

13.        Company Profiles

13.1        Amgen Inc.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Eli Lilly and Company

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        EVER Pharma GmbH

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Polypeptide Group

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        TEVA PHARMACEUTICAL INDUSTRIES LTD

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        AstraZeneca

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Bristol-Myers Squibb Company

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        GlaxoSmithKline plc.

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

13.9        Novo Nordisk A/S

13.9.1        Key Facts

13.9.2        Business Description

13.9.3        Products and Services

13.9.4        Financial Overview

13.9.5        SWOT Analysis

13.9.6        Key Developments

13.10     Sanofi

13.10.1      Key Facts

13.10.2      Business Description

13.10.3      Products and Services

13.10.4      Financial Overview

13.10.5      SWOT Analysis

13.10.6      Key Developments

14.        Appendix

14.1        About The Insight Partners

14.2        Glossary of Terms

LIST OF TABLES

Table 1.              North America Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.              North America Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.              North America Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 4.              North America Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.              US Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.              US Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.              US Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 8.              US Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.              Canada Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.            Canada Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.            Canada Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.            Canada Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.            Mexico Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.            Mexico Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15.            Mexico Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 16.            Mexico Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 17.            Glossary of Terms, Peptide Therapeutics Market

LIST OF FIGURES

Figure 1.            Peptide Therapeutics Market Segmentation

Figure 2.            Peptide Therapeutics Market Segmentation, By Region

Figure 3.            North America Peptide Therapeutics Market Overview

Figure 4.            Innovative Segment Held Largest Share of Peptide Therapeutics Market

Figure 5.            North America Peptide Therapeutics Market – Leading Country Markets (US$ Million)

Figure 6.            North America PEST Analysis

Figure 7.            Peptide Therapeutics Market Impact Analysis of Drivers and Restraints

Figure 8.            North America Peptide Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.            Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

Figure 10.          Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.          Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.          Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 13.          Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.          Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.          Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.          Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.          Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.          Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

Figure 19.          Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.          Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.          Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.          Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

Figure 23.          Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 24.          Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 25.          Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 26.          Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 27.          Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 28.          Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 29.          North America: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 30.          North America Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 31.          North America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)

Figure 32.          US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.          Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.          Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.          Impact of COVID-19 Pandemic in North America Country Markets